Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Mariette

Showing results (51-60 of 594) with videos related to

Pageof 60
Sort By:
Joint Bone Spine|November 4, 2020
Risedronate-induced rhabdomyolysis in a patient with inflammatory myopathyDalia Dimitri, Andoni Echaniz-Laguna, Xavier Mariette
Lancet (London, England)|May 3, 2025
Iscalimab 600 mg: justified or excessive? - Authors' replyBenjamin A Fisher, Xavier Mariette, Wolfgang Hueber
Joint Bone Spine|June 24, 2008
Rituximab: a new therapeutic alternative in rheumatoid arthritisJean Sibilia, Jacques-Eric Gottenberg, Xavier Mariette
Annals of the Rheumatic Diseases|September 28, 2012
Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitorsXavier Mariette, Alan Vaughan Reynolds, Paul Emery
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2021
ReplyElodie Rivière, Juliette Pascaud, Xavier Mariette, et al.
Joint Bone Spine|March 27, 2021
Inflammation-targeted therapies and cancerJoanna Kedra, Gaetane Nocturne, Xavier Mariette, et al.
Joint Bone Spine|December 26, 2024
Transient migratory osteoporosis of epiphyseal lower limbs during FLOT chemotherapy for gastric cancerArthur Bouchut, Gilles Grimon, Xavier Mariette, et al.
Nature Reviews. Rheumatology|April 27, 2021
Systemic and organ-specific immune-related manifestations of COVID-19Manuel Ramos-Casals, Pilar Brito-Zerón, Xavier Mariette
Rheumatology (Oxford, England)|March 7, 2019
Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphomaGaetane Nocturne, Elena Pontarini, Michele Bombardieri, et al.
Arthritis Care & Research|August 30, 2021
Clinically effective concentration and risk of hydroxychloroquine retinopathy in systemic lupus erythematosus: walking on a thin line. Comment on the article by Garg et alSamuel Bitoun, Gaétane Nocturne, Raphaèle Seror, et al.
Pageof 60

Showing results (51-60 of 594) with videos related to

Sort By:
Pageof 60
Joint Bone Spine|November 4, 2020
Risedronate-induced rhabdomyolysis in a patient with inflammatory myopathyDalia Dimitri, Andoni Echaniz-Laguna, Xavier Mariette
Lancet (London, England)|May 3, 2025
Iscalimab 600 mg: justified or excessive? - Authors' replyBenjamin A Fisher, Xavier Mariette, Wolfgang Hueber
Joint Bone Spine|June 24, 2008
Rituximab: a new therapeutic alternative in rheumatoid arthritisJean Sibilia, Jacques-Eric Gottenberg, Xavier Mariette
Annals of the Rheumatic Diseases|September 28, 2012
Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitorsXavier Mariette, Alan Vaughan Reynolds, Paul Emery
Arthritis & Rheumatology (Hoboken, N.J.)|October 25, 2021
ReplyElodie Rivière, Juliette Pascaud, Xavier Mariette, et al.
Joint Bone Spine|March 27, 2021
Inflammation-targeted therapies and cancerJoanna Kedra, Gaetane Nocturne, Xavier Mariette, et al.
Joint Bone Spine|December 26, 2024
Transient migratory osteoporosis of epiphyseal lower limbs during FLOT chemotherapy for gastric cancerArthur Bouchut, Gilles Grimon, Xavier Mariette, et al.
Nature Reviews. Rheumatology|April 27, 2021
Systemic and organ-specific immune-related manifestations of COVID-19Manuel Ramos-Casals, Pilar Brito-Zerón, Xavier Mariette
Rheumatology (Oxford, England)|March 7, 2019
Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphomaGaetane Nocturne, Elena Pontarini, Michele Bombardieri, et al.
Arthritis Care & Research|August 30, 2021
Clinically effective concentration and risk of hydroxychloroquine retinopathy in systemic lupus erythematosus: walking on a thin line. Comment on the article by Garg et alSamuel Bitoun, Gaétane Nocturne, Raphaèle Seror, et al.
Pageof 60